Garmin shares jump 9.4% as Q4 results and 2026 guidance beat expectations, with shareholder returns boosted

Garmin Ltd. (GRMN) is up 9.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears driven by a strong quarterly earnings report paired with better-than-expected full-year 2026 guidance, signaling continued demand strength across Garmin’s product lines. Investors also reacted positively to a proposed dividend increase and an announced share repurchase authorization, both of which can improve total shareholder return.

Details:

Fourth-quarter revenue rose to $2.12 billion and pro forma EPS came in at $2.79, reflecting a solid beat versus typical market expectations for the quarter.

Full-year 2026 guidance called for revenue of about $7.9 billion and pro forma EPS of about $9.35, implying another year of growth from the prior fiscal year.

The company proposed a 17% increase to its dividend, adding to the overall shareholder-return story that can support valuation.

A new $500 million share repurchase program was announced to replace an older authorization, which can provide incremental demand for shares over time.

Sources:

PR Newswire, U.S. Securities and Exchange Commission, Barron's

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$GRMN Insider Trading Activity

$GRMN insiders have traded $GRMN stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $GRMN stock by insiders over the last 6 months:

CHENG-WEI WANG (General Manager - Garmin Corp.) has made 0 purchases and 2 sales selling 10,202 shares for an estimated $2,371,779.
CLIFTON A PEMBLE (President and CEO) has made 0 purchases and 2 sales selling 10,431 shares for an estimated $2,151,162.
PATRICK DESBOIS (co-COO) has made 0 purchases and 2 sales selling 3,678 shares for an estimated $773,868.
DOUGLAS G. BOESSEN (CFO and Treasurer) has made 0 purchases and 3 sales selling 2,964 shares for an estimated $615,743.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$GRMN Hedge Fund Activity

We have seen 435 institutional investors add shares of $GRMN stock to their portfolio, and 540 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,056,852 shares (+inf%) to their portfolio in Q4 2025, for an estimated $214,382,428
AQR CAPITAL MANAGEMENT LLC removed 792,918 shares (-58.8%) from their portfolio in Q4 2025, for an estimated $160,843,416
MAN GROUP PLC added 567,711 shares (+232.0%) to their portfolio in Q4 2025, for an estimated $115,160,176
FMR LLC removed 411,051 shares (-14.5%) from their portfolio in Q4 2025, for an estimated $83,381,695
MARSHALL WACE, LLP added 381,970 shares (+175.5%) to their portfolio in Q4 2025, for an estimated $77,482,614
BANK OF AMERICA CORP /DE/ added 372,550 shares (+100.0%) to their portfolio in Q4 2025, for an estimated $75,571,767
BLACKROCK, INC. removed 364,131 shares (-2.2%) from their portfolio in Q4 2025, for an estimated $73,863,973

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$GRMN Analyst Ratings

Wall Street analysts have issued reports on $GRMN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

Tigress Financial issued a "Strong Buy" rating on 12/19/2025
Longbow Research issued a "Buy" rating on 12/03/2025
Barclays issued a "Underweight" rating on 10/30/2025
Morgan Stanley issued a "Underweight" rating on 10/30/2025

To track analyst ratings and price targets for $GRMN, check out Quiver Quantitative's $GRMN forecast page.

$GRMN Price Targets

Multiple analysts have issued price targets for $GRMN recently. We have seen 4 analysts offer price targets for $GRMN in the last 6 months, with a median target of $212.5.

Here are some recent targets:

Tim Long from Barclays set a target price of $217.0 on 01/16/2026
Ivan Feinseth from Tigress Financial set a target price of $310.0 on 12/19/2025
Erik Woodring from Morgan Stanley set a target price of $195.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.